Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yongping Song

Showing results (171-180 of 252) with videos related to

Pageof 26
Sort By:
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|November 25, 2014
[Breast cancer treat-related acute leukemia: 12 cases report and literatures review]Hao Xu, Xudong Wei, Qingsong Yin, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 3, 2015
[Clinical features and survival analysis of patients with CD20 positive adult B-lineage acute lymphoblastic leukemia]Hao Xu, Xudong Wei, Qingsong Yin, et al.
Scientific Reports|April 20, 2021
Ruxolitinib early administration reduces acute GVHD after alternative donor hematopoietic stem cell transplantation in acute leukemiaBinglei Zhang, Lingyun Chen, Jian Zhou, et al.
Bone Marrow Transplantation|December 7, 2018
Treatment of Epstein-Barr virus associated central nervous system diseases after allogeneic hematopoietic stem cell transplantation with intrathecal donor lymphocyte infusionJuanjuan Zhao, Yingling Zu, Lijie Han, et al.
Cancer Biology & Medicine|August 14, 2021
Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignanciesLu Han, Jian Zhou, Linlin Li, et al.
Frontiers in Immunology|October 13, 2022
Case Report: Successful engraftment of allogeneic hematopoietic stem cells using CAR-T cell therapy as the conditioning regimen in R/R Ph<sup>+</sup> B cell acute lymphoblastic leukemiaLu Han, Ran Zhao, Jingyi Yang, et al.
Journal of Hematology & Oncology|December 19, 2024
Safety and efficacy of amulirafusp alfa (IMM0306), a fusion protein of CD20 monoclonal antibody with the CD47 binding domain of SIRPα, in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: a phase 1/2 studyJianliang Yang, Yongping Song, Keshu Zhou, et al.
Platelets|March 26, 2015
The polymorphisms of tumor necrosis factor-induced protein 3 gene may contribute to the susceptibility of chronic primary immune thrombocytopenia in Chinese populationHu Zhou, Jingyi Yang, Liu Liu, et al.
British Journal of Haematology|October 6, 2022
Reduced-dose post-transplant cyclophosphamide plus low-dose post-transplant anti-thymocyte globulin as graft-versus-host disease prophylaxis with fludarabine-busulfan-cytarabine conditioning in haploidentical peripheral blood stem cell transplantation: A multicentre, randomized controlled clinical trialWenli Zhang, Ruirui Gui, Yingling Zu, et al.
Chinese Medical Journal|June 6, 2024
Identification of potential immune-related mechanisms related to the development of multiple myelomaYaomei Wang, Wenli Zhang, Tiandong Li, et al.
Pageof 26

Showing results (171-180 of 252) with videos related to

Sort By:
Pageof 26
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|November 25, 2014
[Breast cancer treat-related acute leukemia: 12 cases report and literatures review]Hao Xu, Xudong Wei, Qingsong Yin, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 3, 2015
[Clinical features and survival analysis of patients with CD20 positive adult B-lineage acute lymphoblastic leukemia]Hao Xu, Xudong Wei, Qingsong Yin, et al.
Scientific Reports|April 20, 2021
Ruxolitinib early administration reduces acute GVHD after alternative donor hematopoietic stem cell transplantation in acute leukemiaBinglei Zhang, Lingyun Chen, Jian Zhou, et al.
Bone Marrow Transplantation|December 7, 2018
Treatment of Epstein-Barr virus associated central nervous system diseases after allogeneic hematopoietic stem cell transplantation with intrathecal donor lymphocyte infusionJuanjuan Zhao, Yingling Zu, Lijie Han, et al.
Cancer Biology & Medicine|August 14, 2021
Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignanciesLu Han, Jian Zhou, Linlin Li, et al.
Frontiers in Immunology|October 13, 2022
Case Report: Successful engraftment of allogeneic hematopoietic stem cells using CAR-T cell therapy as the conditioning regimen in R/R Ph<sup>+</sup> B cell acute lymphoblastic leukemiaLu Han, Ran Zhao, Jingyi Yang, et al.
Journal of Hematology & Oncology|December 19, 2024
Safety and efficacy of amulirafusp alfa (IMM0306), a fusion protein of CD20 monoclonal antibody with the CD47 binding domain of SIRPα, in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: a phase 1/2 studyJianliang Yang, Yongping Song, Keshu Zhou, et al.
Platelets|March 26, 2015
The polymorphisms of tumor necrosis factor-induced protein 3 gene may contribute to the susceptibility of chronic primary immune thrombocytopenia in Chinese populationHu Zhou, Jingyi Yang, Liu Liu, et al.
British Journal of Haematology|October 6, 2022
Reduced-dose post-transplant cyclophosphamide plus low-dose post-transplant anti-thymocyte globulin as graft-versus-host disease prophylaxis with fludarabine-busulfan-cytarabine conditioning in haploidentical peripheral blood stem cell transplantation: A multicentre, randomized controlled clinical trialWenli Zhang, Ruirui Gui, Yingling Zu, et al.
Chinese Medical Journal|June 6, 2024
Identification of potential immune-related mechanisms related to the development of multiple myelomaYaomei Wang, Wenli Zhang, Tiandong Li, et al.
Pageof 26